Showing results (1-10 of 527) with videos related to
Sort By:
Pageof 53
Cancer|February 28, 2017
Immune checkpoint inhibitors in challenging populationsDouglas B Johnson, Ryan J Sullivan, Alexander M MenziesThe Lancet. Oncology|August 1, 2014
Systemic treatment for BRAF-mutant melanoma: where do we go next?Alexander M Menzies, Georgina V LongTherapeutic Advances in Medical Oncology|September 3, 2013
New combinations and immunotherapies for melanoma: latest evidence and clinical utilityAlexander M Menzies, Georgina V LongFuture Oncology (London, England)|June 12, 2025
POLARIS: encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasisAlexander M Menzies, Michael A DaviesEuropean Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondAlexander M Menzies, Georgina V LongClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanomaAlexander M Menzies, Georgina V LongEuropean Journal of Cancer (Oxford, England : 1990)|January 22, 2020
Intratumoural immunotherapies in oncologyWen Xu, Victoria G Atkinson, Alexander M MenziesInternal Medicine Journal|March 19, 2021
Recent advancements in melanoma managementTharani Krishnan, Alexander M Menzies, Rachel Roberts-ThomsonDrug Design, Development and Therapy|December 20, 2012
Dabrafenib and its potential for the treatment of metastatic melanomaAlexander M Menzies, Georgina V Long, Rajmohan MuraliCancer|May 26, 2017
Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanomaSu Yin Lim, Alexander M Menzies, Helen RizosPageof 53